Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ImmunoGen Inc lowers FY 2014 outlook


Friday, 25 Apr 2014 06:30am EDT 

ImmunoGen Inc:Expects FY 2014 revenues between $60-$64 mln, compared with previous guidance of between $71-$75 mln.Expects FY 2014 net loss to be between $71-$75 mln, compared with previous guidance of between $67-$71 mln.FY 2014 revenue of $76 mln - Thomson Reuters I/B/E/S. 

Company Quote

9.84
 --
25 Nov 2014